SCFV - LOC314509 similar to single chain Fv antibody fragment scFv 7-10A Gene
Species: Rattus norvegicus
Gene Type: other
Gene ID: 314509
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive MoleculesInhibitory Antibodies
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P990688 | Xaluritamig | Inhibitor | ≥99% | Phase 3 |
| HY-P99886 | Pexelizumab | Inhibitor | 99.0% | Phase 3 |
| HY-P99772 | Onfekafusp alfa | / | Phase 3 | |
| HY-P99521 | Vibecotamab | 99.34% | Phase 2 | |
| HY-P990920 | Gocatamig | Inhibitor | ≥99.0% | Phase 2 |
| HY-P990314 | AFM24 | Inhibitor | 96.26% | Phase 2 |
| HY-P990730 | Cabotamig | Inhibitor | 99.88% | Phase 1 |
| HY-P991671 | Anafiltamig | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P4043 | Hepatitis b virus pre-s region (120-145) | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(15)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990717 | Brenetafusp | Inhibitor | 99.70% | Unkown |
| HY-P990903 | Avitotamig | Inhibitor | 95.98% | Unkown |
| HY-P990735 | Donzakimig | 98.67% | Unkown | |
| HY-P990714 | Obertamig | Inhibitor | 95.803% | Unkown |
| HY-P991461 | AMG-424 | Inhibitor | 99.32% | Unkown |
| HY-P990695 | Lunaxafusp | Inhibitor | / | Unkown |
| HY-P990939 | Podentamig | Inhibitor | / | Unkown |
| HY-P991151 | Opamtistomig | Inhibitor | / | Unkown |
| HY-P990912 | Cugrastomig | 98.46% | Unkown | |
| HY-P990935 | Opugotamig | 99.67% | Unkown | |
| HY-P990574 | Derlotuximab | Inhibitor | / | Unkown |
| HY-P991101 | Anti-Amyloid Beta Antibody (scFv59) | Inhibitor | / | Unkown |
| HY-P991147 | Ledostomig | Inhibitor | / | Unkown |
| HY-P992184 | Anti-5T4 scFv-Fc Antibody | / | Unkown | |
| HY-P992232 | Anti-GFRA4 Antibody (scFv) | Inhibitor | / | Unkown |